Filing Details

Accession Number:
0001209191-24-001065
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-01-05 18:26:51
Reporting Period:
2024-01-04
Accepted Time:
2024-01-05 18:26:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1741830 Kronos Bio Inc. KRON Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1763316 Barbara Kosacz C/O Kronos Bio, Inc.
1300 So. El Camino Real, Suite 400
San Mateo CA 94402
Coo & General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-01-04 10,676 $1.18 928,966 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Represents shares sold to satisfy estimated tax withholding obligations upon the settlement of restricted stock units.
  2. The weighted average sale price for the transaction reported was $1.1836, and the range of prices were between $1.12 to $1.28. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.